Hypothalamic mechanisms of obesity-associated disturbance of hypothalamic-pituitary-ovarian axis

Trends Endocrinol Metab. 2022 Mar;33(3):206-217. doi: 10.1016/j.tem.2021.12.004. Epub 2022 Jan 18.

Abstract

Ovulatory disorders are the most common clinical feature exhibited among obese women. Initiation of ovulation physiologically requires a surge of gonadotropin-releasing hormone (GnRH) released from GnRH neurons located in the hypothalamus. These GnRH neurons receive metabolic signals from circulation and vicinal neurons to regulate GnRH release. Leptin acts indirectly on GnRH via adjacent leptin receptor (LEPR)-expressing neurons such as proopiomelanocortin (POMC), neuropeptide Y (NPY)/agouti-related peptide (AgRP), and neuronal nitric oxide (NO) synthase (nNOS) neurons to affect GnRH neuronal activities. Additionally, hypothalamic inflammation also affects ovulation independent of obesity. Therefore, this review focuses on hypothalamic mechanisms that underlie the disturbance of hypothalamic-pituitary-ovarian (HPO) axis during obesity with an attempt to promote future studies and/or novel therapeutic strategies for ovulatory disorders in obesity.

Keywords: gonadotropin-releasing hormone; hypothalamic–pituitary–ovarian axis; hypothalamus; leptin; neurons; obesity.

Publication types

  • Review

MeSH terms

  • Female
  • Gonadotropin-Releasing Hormone / metabolism
  • Humans
  • Hypothalamus* / metabolism
  • Neuropeptide Y / metabolism
  • Obesity / metabolism
  • Ovary
  • Pituitary Gland
  • Pro-Opiomelanocortin* / metabolism

Substances

  • Neuropeptide Y
  • Gonadotropin-Releasing Hormone
  • Pro-Opiomelanocortin